Skip to main content

Sphingotec GmbH

Hohen Neuendorf, Germany

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

$5.5M raised
Aug 2024
Series C

Top Investors

Wellington PartnersNRW.BANKBrandenburg KapitalHBM PartnersHBM Healthcare Investments

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sphingotec GmbH

How much funding has Sphingotec GmbH raised?
Sphingotec GmbH has raised $5.5M in total funding. The most recent round was Series C. The last funding was announced in August 2024.
Who are Sphingotec GmbH's investors?
Sphingotec GmbH's investors include Wellington Partners, NRW.BANK, Brandenburg Kapital, HBM Partners, HBM Healthcare Investments.
Where is Sphingotec GmbH headquartered?
Sphingotec GmbH is headquartered in Hohen Neuendorf, Germany.
What does Sphingotec GmbH do?
SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.
What stage is Sphingotec GmbH at?
Sphingotec GmbH is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sphingotec GmbH — Funding & Investors." VCBacked, August 8, 2024, https://www.vcbacked.co/company/sphingotec-gmbh. Accessed June 23, 2026.
APA
VCBacked. (2024). Sphingotec GmbH — Funding & Investors. Retrieved June 23, 2026, from https://www.vcbacked.co/company/sphingotec-gmbh
Wikipedia (cite web)
{{cite web |title=Sphingotec GmbH — Funding & Investors |url=https://www.vcbacked.co/company/sphingotec-gmbh |website=VCBacked |access-date=June 23, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .